Background Self-report measures of medication nonadherence confound the extent of and reasons for medication nonadherence. Each construct is assessed with a different type of psychometric model, which dictates how to establish reliability and validity.
M edication nonadherence is a significant clinical problem in chronic disease management. 1, 2 Medication nonadherence is associated with increased health care spending, hospitalization rates, morbidity, and premature mortality. 3 Obtaining accurate estimates of medication nonadherence is essential to determine where intervention resources should be directed. There is no "gold standard" for assessing nonadherence. 4, 5 Pill refills, pill counts, and computerized bottle caps can approximate how much medication patients are consuming, but only patients can report reasons for not taking their medications. The self-report method is also appealing because it can be administered in any setting, is low cost, and can provide immediate feedback at the point of care.
Considerable effort has been made to assess self-reported medication nonadherence, yielding several self-report instruments. [6] [7] [8] [9] Although an expert committee recently identified medication nonadherence as one of the constructs that should be assessed routinely in electronic health records, it did not recommend an existing measure and suggested that further work was needed. 10 Others have also concluded that the existing measures lacked reliability and validity. 11 Recently, we examined existing self-report measures of medication nonadherence to determine how measurement could be improved. 12 A key limitation of existing measures is that they confound 2 related but distinct nonadherence constructs: the extent to which doses are missed and the reasons for missing doses. Each construct is assessed by a different type of psychometric model, which has important measurement implications (Table 1) . Existing self-report measures were not developed with this distinction in mind, compromising reliability and validity. 12 We developed a self-report measure that assesses the extent of and reasons for medication nonadherence separately using appropriate psychometric models. We developed the measure within the context of hypertension (HTN) because its prevalence is high and nonadherence to antihypertensive medications is common. 13, 14 We provide initial validation results.
METHODS

Item Generation
To inform items assessing the extent of nonadherence, cognitive interviews were conducted at the Duke University with hypertensive patients: 15 with English-speaking black and white patients and 15 with Spanish-speaking patients. Participants were asked to discuss how the following wording choices would affect their estimates of the extent of nonadherence: (1) percentage versus frequency of doses; and (2) recall period of last week versus last month. Patients found it difficult to quantify behavior in terms of percentages. Patients had various interpretations of the phrases "last week" and "last month," suggesting the need to ask about a specific number of days. Although some patients thought that the "last 30 days" more accurately reflected long-term adherence, they felt that "the last 7 days" were more easily and accurately recalled and more sensitive to nonadherence. These findings were used to generate our initial item pool comprising 5 items asking about medication use over the previous 7 days.
To generate reasons for nonadherence, we used the 23 situations queried in the Medication Adherence Self-Efficacy Scale. 15 Our review of the literature and focus groups conducted previously 16 did not reveal additional situations. The recall period for these items was also 7 days.
Design of Validation Study
The study involved 2 in-person assessments. At time 1, the newly developed nonadherence measure and several psychosocial measures were administered. At time 2 (2-21 d later), the newly developed measure was readministered to provide initial evidence of stability. Blood pressure (BP) was obtained at both the visits to provide evidence of concurrent validity.
Participants
Participants were recruited from the Durham Veterans Affairs Medical Center, where Institutional Review Board approval was obtained. Veterans older than 40 years with a diagnosis of HTN were identified from electronic medical records. Inclusion criteria determined during a screening telephone call were: prescription of at least 1 antihypertensive medication, stability of antihypertensive regimen for at least 3 months prior, and receipt of antihypertensive medications from Durham Veterans Affairs Medical Center. Exclusion criteria were: cognitive impairment based on a 6-item screener, 17 unable to complete questionnaires unaided, unable to communicate in English or by telephone, resident in a nursing home or receiving home health care, or health problem that precludes participation.
Recruitment and Study Procedures
Patients meeting initial inclusion criteria received a recruitment letter and telephone call. Eligible patients were scheduled for an assessment, which coincided with a scheduled medical appointment when possible. Reminder letters were mailed before the visit and included instructions not to smoke or consume caffeine or alcohol for at least 60 minutes before the assessment.
At time 1, the research assistant conducted the consent process, obtained 2 BP readings according to recommended standards, 18 and administered the self-report measures orally. At time 2, the research assistant obtained 2 BP readings and administered the new nonadherence measure orally. Participants received $20 for each assessment.
Measures
At time 1, we collected demographic data, medication names, and dosing instructions in addition to the measures listed below.
Extent of Nonadherence
Participants rated the extent to which they have missed doses of their medications over the past 7 days by 5 items with response options: strongly disagree, strongly agree, neutral, agree, and strongly agree. Higher scores indicate greater levels of nonadherence. 
Self-Efficacy to Take Antihypertensive Medication
Self-efficacy to take medication as prescribed was assessed with the 13-item Medication Adherence Self-Efficacy Scale-Revised, 15 in which participants rated how sure they are that they can take their medication in certain situations. The internal consistency (estimated using Cronbach coefficient-a, hereafter referred to as a) in our sample was 0.94.
Beliefs About Medicines
The 18-item Beliefs about Medicines Questionnaire (BMQ) 19 comprises of 4 factors: beliefs about the necessity of prescribed medication (Specific-Necessity; a = 0.84); beliefs about the danger of dependence and long-term toxicity and the disruptive effects of medication (Specific-Concerns; a = 0.78); beliefs that medicines are harmful, addictive poisons that should not be taken continuously (General-Harm; a = 0.74; and beliefs that medicines are overused by doctors (General-Overuse; a = 0.80). Higher scores indicate more positive beliefs about medications for the Necessity factor, and lower scores indicate more positive beliefs about medications on the others.
Impression Management
Participants completed the 20-item Impression Management subscale of the Balanced Inventory of Desirable Responding 20 to assess the tendency to portray a positive perception to others (a = 0.72).
Conscientiousness
Participants indicated how well 25 adjectives described them from 1 very inaccurate to 5 very accurate. This scale was designed to assess facets of conscientiousness. Items were presented in a different random order for each participant to minimize order effects. Fifteen of the items yielded 3 facets: orderliness (a = 0.84), impulse control (a = 0.63), and reliability (a = 0.80). The remaining 10 items not contributing to a facet in an exploratory factor analysis were not analyzed.
Habit Strength
The habit strength measure was adapted from previous measures 21, 22 to assess the frequency of medication-taking behavior with 1 item and situational consistency with 5 additional items (physical location, time of day, people present, mood, and event). Habit strength was calculated as the product of frequency and the mean of the 5 situational consistency items.
BP
All BP measurements were performed using a digital sphygmomanometer. Participants sat quietly for 5 minutes. Arm circumference was measured for the appropriate size cuff, and BP was measured while participants were sitting in a chair with back rested, both feet on the floor, and arm supported at heart level. A second reading was obtained 1 minute later. The average of the 2 BP readings was used in analyses.
Existing Measure of Self-Reported Nonadherence
Participants completed the 8-item version of the Morisky scale. 7 Two items (2 and 5) assess the extent of nonadherence over 2 weeks and yesterday, and 6 items assess reasons for nonadherence: forgetting (items 1, 4, and 8), feeling worse (item 3), BP in control (item 6), and feeling hassled (item 7). A summary score was calculated. 7 This scale was administered to provide evidence of convergent validity of the extent measure and to gain initial evidence as to whether separating extent from reasons improves the relationship with the criterion (BP).
Analysis
The extent of nonadherence is represented by an effect indicator model, in which a person's level of medication nonadherence determines their item (indicator) responses. 23 Descriptive statistics were examined for all extent items. Excessive skewness is indicated by values >2 and excessive kurtosis by values >7. 24 Internal consistency and confirmatory factor analysis (CFA) were conducted to examine the extent to which a single latent variable contributed to indicators of extent of nonadherence. CFA is an inferential test of the hypothesis that a single factor accounts for the data. Because of the small item set, a 2-factor model was not tested. To set the metric for the CFA model, all factor loadings were freely estimated, and the latent factor's variance was set to 1. Because of the non-normal item distributions, the response scales were treated as ordinal by specifying categorical variable type. Incremental model fit was assessed by the Comparative Fit Index (CFI) 25 and TuckerLewis Index (TLI) 26 ; values >0.95 are generally accepted as good model fit. 27 Absolute model fit was assessed by Weighted Root Mean Square Residual (WRMR), for which values <0.90 are generally accepted as good fit. 28 Extent items were considered for elimination due to excessive missingness, skewness, or kurtosis; insufficient interitem and item-total correlations or factor loadings (< 0.40) 29 ; improvement in a once an item was deleted; or redundancy with other items, as indicated by interitem correlations and factor loadings much higher than those for other item pairs. The mean of all retained items was calculated and used in all analyses (see Data, Supplemental Digital Content 2, http:// links.lww.com/MLR/A333 which includes the item response theory analyses).
Pearson correlations were computed between extent and comparison measures to provide information about convergent and discriminant validity. As an a priori guideline, any correlation >0.50 was considered as evidence of convergent validity and any correlation <0.30 as evidence of discriminant validity. Because self-efficacy is a proximal determinant of behavior, we expected a large correlation between extent and medication self-efficacy. We also expected a large correlation between extent and the Morisky scale to provide evidence of convergent validity because some Morisky items assess missed doses. We expected small correlations between extent and the 4 BMQ subscales, impression management, conscientiousness, and habit strength to provide evidence of discriminant validity. Because factors other than nonadherence contribute to elevated BP, 30 we expected a small to moderate correlation between BP and extent to provide evidence of predictive validity.
Reasons for nonadherence are represented by a causal indicator model, in which each reason for nonadherence stands alone as a descriptive indicator for the construct because they would not necessarily be correlated. 12 Participants indicating any nonadherence (scoreZ2 on any extent item) were considered nonadherent, 31 and descriptive statistics for their reasons items were examined (see Figure, Supplemental Digital Content 3, http://links.lww.com/MLR/A335 which includes the histograms). Reasons items were expected to be skewed and/or kurtotic and not highly intercorrelated. We determined a priori that reasons items highly correlated (r > 0.60) with one another would be examined for possible redundancy. Alpha was not calculated because it is inappropriate for causal indicators. 23 To examine the test-retest reliability of the nonadherence measures, intraclass correlations (ICC) were calculated for the extent summary score and each reason using a 2-way mixed model with time as a fixed variable and participants as a random variable. 32 Test-retest reliability assumes the nonadherence constructs are stable over the 2 assessment periods (which ranged from 2 to 21 d). For participants whose reference periods for the assessment points do not align, there is concern about the stability of the nonadherence constructs, especially for the reasons scale as reasons for missing a medication may change over time. Thus, we are neither confident that test-retest reliability alone is an accurate indicator of reliability, nor should it be used alone as the only indicator to retain or remove an item from the scale.
The target sample size was 200, which provides >99.5% power to detect the significance of a correlation of Z0.30 at P = 0.05. The CFA was performed using Mplus (version 6). The remaining analyses were performed using SAS (version 9; SAS Institute, Cary, NC).
RESULTS
A total of 740 recruitment letters were mailed, for which 566 patients were contacted by telephone. Of those, 100 were ineligible, 210 refused, 6 died before contact, and 250 were scheduled for a time 1 visit. Of the 250, 48 did not show for their appointment, leaving a time 1 n of 202 (36%). Of those, 186 (92%) returned for the time 2 visit.
Participants were 64 years on average, of mixed racial composition, and primarily male ( Table 2) . Nearly three quarters of participants reported some education beyond high school, and only 10% reported insufficient income to pay bills.
Extent of Nonadherence
Although the means of all extent items except item 4 were below the scale midpoint, the distributions were not highly skewed or kurtotic (Table 3 ). All items except item 4 had adequate item-total and interitem correlations. A single factor accounted for the shared variance among the 5 extent items, w 2 5 = 25.61, P = 0.0001, CFI = 0.99, TLI = 0.99, WRMR = 0.60. Although all items had sufficient factor loadings, the item 4 loading was lower than for the other items. Items 1 and 2 were substantially correlated (r = 0.84), suggesting redundancy between them. Item 2 was retained in favor of item 1 because its wording is more specific, and item 4 was eliminated because it measures a related but different construct (ie, being late for a dose). Items 2, 3, and 5 were averaged (unweighted) to create a final summary score, M = 1.78 (SD = 0.96). These items produced reliable scores, a = 0.84 (95% confidence interval, 0.80-0.87).
As expected, extent was highly correlated with medication self-efficacy (Table 4) . Although correlations between extent and the harm subscale of the BMQ and habit strength were > 0.30, they were not so high as to indicate measurement of a similar construct. Correlations between extent and the necessity, concerns, and overuse subscales of the BMQ, impression management, and the 3 facets of conscientiousness were small in magnitude, demonstrating discriminant validity. Finally, predictive validity was evidenced by correlations between extent and BP: for systolic, r 202 = 0.27, P < 0.0001 and for diastolic, r 202 = 0.27, P < 0.0001.
Reasons for Nonadherence
Means of the reasons items were well below the scale midpoint, and several distributions were positively skewed and kurtotic (Table 5 ). Sixty percent (N = 122) of participants were considered nonadherent (Z2 on any extent item). The reason endorsed (scoreZ2) most was I forgot (27%). The least commonly endorsed reasons were feeling too ill to take them (7%) and going on a long car/plane/bus ride (7%).
As expected, interitem correlations were, with few exceptions, sufficiently small to suggest that these items are capturing independent reasons for nonadherence (range, À 0.01 to 0.81, average r = 0.28). Item 17 (I felt well) was eliminated because it was highly correlated with and subsumed by item 13 (I felt I did not need them). Item 23 (I was going on a long car/bus/plane ride) was eliminated because it was highly correlated with and subsumed by item 14 (I was traveling). The result was a list of 21 relatively independent reasons for nonadherence (range, À 0.01 to 0.64, average r = 0.28).
Relationship With Existing Measure of Nonadherence
To demonstrate the value of treating nonadherence as 2 related yet distinct constructs, we examined the structure of the Morisky scale (see Data, Supplemental Digital Content 4, http://links.lww.com/MLR/A334 which includes results of a CFA). Items 2 and 5, assessing extent of nonadherence, were only correlated at r = 0.13. Interitem correlations for the remaining items, assessing reasons for nonadherence, ranged from À 0.10 to 0.55, average r = 0.22. Thus, the Morisky scale did not measure a single underlying construct in this sample. The correlation between the Morisky total score and extent was r 202 = À 0.62, P < 0.0001, providing evidence of convergent validity of our extent measure. The Morisky score was not correlated with BP: systolic r 202 = À 0.03, P = 0.68 and diastolic r 202 = À 0.02, P = 0.74. (Table 3) , and the 3-item total score was r = 0.58, demonstrating moderate short-term stability in the extent of nonadherence. ICCs for the reasons items varied greatly, ranging from 0.07 to 0.64 (Table 5 ).
Stability of Nonadherence Over Time
DISCUSSION
Our self-report measure reflects a dual conceptualization of nonadherence. 12 Although related, the 2 facets are distinct, requiring different measurement approaches and Response scales ranged from 1 (strongly disagree) to 5 (strongly agree), with greater scores indicating greater levels of nonadherence.
CI indicates confidence interval; ICC, intraclass correlation. evaluation using different psychometric models. Consistent with our conceptualization, the extent of nonadherence was assessed with 3 positively correlated items, which produced reliable scores and correlated as expected with related constructs. Also consistent with our conceptualization, reasons for nonadherence were assessed with several independent items. In contrast to the extent items, which are averaged into an overall score, the reasons items are treated individually in a descriptive manner to inform treatment decisions or to tailor interventions to increase adherence. Although short measures are always desirable for research and clinical settings, reliability and validity must be a priority. Multiple items (in this case, 3), rather than a single item, are needed to assess the extent of nonadherence because the reliability, and therefore predictive validity, of effective indicators is increased by the use of multiple items. Some portion of the unreliability in individual items is not shared with other items that vary in wording and, as such, the composite score, which reflects the commonality across items, reduces the impact of unreliability on scores.
The need to assess the reasons for nonadherence with many items to provide construct validity is underscored by the endorsement of individual items by only a small proportion of participants and by the lack of sizable interitem correlations. Future research is needed to determine whether the improved content validity translates to better ability to detect intervention outcomes or improves clinical practice.
One practical advantage of measuring extent and reasons separately is that the measurement process can be streamlined: The 3 extent items can be used to help identify patients with suboptimal levels of adherence, followed by the reasons items to identify targets of intervention if necessary. This approach is similar to depression screening, where a positive 2-item Patient Health Questionnaire is followed by a more comprehensive depression measure or diagnostic interview. 33 Although the response scale for extent items is continuous, various cutoffs could classify nonadherent individuals, depending on a researcher's or clinician's goals.
Another advantage of measuring the 2 constructs separately is that longitudinal assessments may provide a more fine-grained picture of medication-taking behavior. Previous studies have suggested that adherence is episodic. 34 Because of the content of existing self-report measures, it is difficult to determine whether the extent of nonadherence or the reasons for nonadherence vary over time. The separate measurement of extent and reasons in this self-report measure enables independent assessment of both the constructs. The ICCs for extent individual items and total score were moderate to large over 2-21 days, suggesting that some individuals report a consistent level of nonadherence. In contrast, ICCs for many reasons items were more modest, indicating that some reasons for nonadherence are highly variable. More research is needed to elucidate longitudinal patterns of medication-taking behavior, which could inform intervention development and clinical practice.
As scale development is an iterative and ongoing process, we will continue to refine the measure and build the body of evidence for its reliability and validity. For example, because the extent items and response scales were not subjected to cognitive interviews, cognitive interviews should be conducted to improve further the instructions and evaluate different response scales. More evidence of convergent validity of the extent measure could be obtained by comparing it to electronic medication monitoring, commonly characterized as a more objective method. 35 More evidence of criterion-related validity is needed as well. Although the extent and Morisky measures were highly correlated, only the extent measure was significantly associated with BP. Thus, despite some shared variance between the extent and the Morisky scales, they account for different variance in BP. This pattern of correlations should be examined in other samples to provide more evidence on the predictive validity of the new measure. Criterion-related validity may be difficult to establish in HTN because BP is highly variable and reflects the influence of other factors. 30, 36 In diseases in which the outcome is more stable over time, such as low-density lipoprotein cholesterol treated by statins, a higher correlation might be expected between extent and the criterion.
Equally important is establishing the psychometric properties of this measure in other diseases and patient populations. As expected of effect indicator models, the extent measure should have stable psychometric properties across diseases and populations. The reasons measure will need to be tailored to characteristics of the disease, patient populations, and medications used.
In summary, the dual conceptualization of the extent of nonadherence and reasons for nonadherence provided a framework for the measurement of these constructs. Using this conceptualization, we developed a preliminary version of a measure to assess these facets separately, thereby allowing a stronger evaluation of the reliability and validity than was possible with existing measures. By improving the measurement of self-reported nonadherence, we hope to enable better evaluation of interventions to improve patientcentered outcomes and clinical practice.
